Whole Brain Irradiation in Primary Central Nervous System (CNS) Lymphoma (PCNSL)

This study has been completed.

Sponsor:

Collaborator:

University Hospital Tuebingen

Information provided by:

Charite University, Berlin, Germany

ClinicalTrials.gov Identifier:

NCT00153530

First received: September 8, 2005

Last updated: December 23, 2009

Last verified: July 2009

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	May 2009
Estimated Primary Completion Date:	No date given

No publications provided by Charite University, Berlin, Germany

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Thiel E, Korfel A, Martus P, Kanz L, Griesinger F, Rauch M, Röth A, Hertenstein B, von Toll T, Hundsberger T, Mergenthaler HG, Leithäuser M, Birnbaum T, Fischer L, Jahnke K, Herrlinger U, Plasswilm L, Nägele T, Pietsch T, Bamberg M, Weller M. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial. Lancet Oncol. 2010 Nov;11(11):1036-47. Epub 2010 Oct 20.

To Top